# Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia

> **NCT00176423** · PHASE4 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 117 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** galantamine

## Key facts

- **NCT ID:** NCT00176423
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2020-12-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00176423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00176423, "Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00176423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*